NCT00343395View on ClinicalTrials.gov

Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study

PHASE4TerminatedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

January 31, 2008

Conditions
Coronary Artery Disease
Interventions
DRUG

AVANDAMET

2/500 mg

Trial Locations (1)

84157

Intermountain Medical Center, Murray

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Intermountain Health Care, Inc.

OTHER

NCT00343395 - Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study | Biotech Hunter | Biotech Hunter